7OC.DU - ONCOCYTE CORP.

Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2018
31/12/2017
31/12/2016
31/12/2015
Cash flows from operating activities
Net income
-16,717
-15,754
-19,375
-11,168
-8,735
Depreciation & amortisation
425
559
580
387
283
Deferred income taxes
-
-
-
-
-
Stock-based compensation
2,132
1,479
1,630
922
1,815
Change in working capital
-664
993
-686
2,337
2,325
Accounts receivable
-
-
-
-
-
Inventory
-
-
-
-
-
Accounts payable
1,768
1,002
-48
-
-
Other working capital
-14,524
-11,680
-13,476
-7,628
-4,729
Other non-cash items
118
100
4,157
922
83
Net cash provided by operating activities
-14,497
-11,649
-13,385
-7,522
-4,229
Cash flows from investing activities
Investments in property, plant and equipment
-27
-31
-91
-106
-500
Acquisitions, net
-
-
-
-
-
Purchases of investments
-
-
-
-
-
Sales/maturities of investments
-
0
934
0
-
Other investing activities
-
-
-
-75
815
Net cash used for investing activities
27
-31
843
-181
315
Cash flows from financing activities
Debt repayment
-1,243
-1,181
-398
-114
-
Common stock issued
43,842
13,592
0
10,550
11,649
Common stock repurchased
-
-
-
-
-
Dividends paid
-
-
-
-
-
Other financing activities
-3,542
-355
-
-773
0
Net cash used provided by (used for) financing activities
40,002
12,114
9,968
9,881
11,653
Net change in cash
25,532
434
-2,574
2,178
7,739
Cash at beginning of period
10,294
7,600
10,174
7,996
257
Cash at end of period
35,826
8,034
7,600
10,174
7,996
Free cash flow
Operating cash flow
-14,497
-11,649
-13,385
-7,522
-4,229
Capital expenditure
-27
-31
-91
-106
-500
Free cash flow
-14,524
-11,680
-13,476
-7,628
-4,729
By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more